Jessica Chubak, PhD

Chubak_Jessica__205x293.jpg

“My research focuses on improving cancer control by finding effective ways to get screened for cancer and to navigate treatment and survivorship.”

Jessica Chubak, PhD

Senior Investigator, Kaiser Permanente Washington Health Research Institute

Biography

Jessica Chubak, PhD, is an epidemiologist who works to improve cancer diagnosis, treatment, control, and survivorship. She contributes to several national collaborations that are finding practical, efficient, effective ways to screen for cancer, especially colorectal cancer. She also studies how common medications affect cancer risk and recurrence. Intrigued by how pets positively affect health, Dr. Chubak is studying animal-assisted activities in clinics and hospitals where children get treated for cancer. Dr. Chubak’s methodological research focuses on the use of administrative and electronic health record data in epidemiologic and health services studies.

Dr. Chubak joined KPWHRI in 2007, bringing expertise in epidemiologic methods, pharmacoepidemiology, and cancer. Awarded a Fulbright graduate student grant, Dr. Chubak pursued her master's degree in bioethics and health law in New Zealand before completing her PhD in Epidemiology at the University of Washington (UW). Dr. Chubak is an affiliate associate professor in the Department of Epidemiology at the UW School of Public Health, where she enjoys guest-lecturing and getting to work with students.

Research interests and experience

 

Recent publications

Feldman S, Lykken JM, Haas JS, Werner CL, Kobrin SC, Tiro JA, Chubak J, Kamineni A. Factors associated with timely colposcopy following an abnormal cervical cancer test result. Prev Med. 2022 Oct 18;164:107307. doi: 10.1016/j.ypmed.2022.107307. [Epub ahead of print]. PubMed

Chubak J, Pocobelli G, Ziebell RA, Hawkes RJ, Adler A, Bobb JF, Zerr DM. Effects of the COVID-19 pandemic on animal-assisted activities in pediatric hospitals. J Pediatr Health Care. 2022 Sep 30:S0891-5245(22)00281-4. doi: 10.1016/j.pedhc.2022.09.011. [Epub ahead of print]. PubMed

Kamineni A, Doria-Rose VP, Chubak J, Inadomi JM, Corley DA, Haas JS, Kobrin SC, Winer RL, Lafata JE, Beaber EF, Yudkin JS, Zheng Y, Skinner CS, Schottinger JE, Ritzwoller DP, Croswell JM, Burnett-Hartman AN. Evaluation of harms reporting in U.S. cancer screening guidelines. Ann Intern Med. 2022 Sep 27. doi: 10.7326/M22-1139. Online ahead of print. PubMed

Chubak J, Dalmat RR, Weiss NS, Doria-Rose VP, Corley DA, Kamineni A. Informative presence in electronic health record data: a challenge in implementing study exclusion criteria. Epidemiology. 2022 Sep 16. doi: 10.1097/EDE.0000000000001542. Online ahead of print. PubMed

Chao CR, Chubak J, Beaber EF, Kamineni A, Mao C, Silverberg MJ, Tiro JA, Skinner C, Garcia M, Corley DA, Winer RL, Raine-Bennett T, Feldman S, Wheeler CM. Gaps in the screening process for women diagnosed with cervical cancer in four diverse US health care settings. Cancer Med. 2022 Sep 15. doi: 10.1002/cam4.5226. Online ahead of print. PubMed

Dalmat RR, Ziebell RA, Kamineni A, Phipps AI, Weiss NS, Breslau ES, Corley DA, Green BB, Halm EA, Levin TR, Schottinger JE, Chubak J. Risk of colorectal cancer and colorectal cancer mortality beginning ten years after a negative colonoscopy, among screen-eligible adults 76-85 years old. Cancer Epidemiol Biomarkers Prev. 2022 Sep 13:EPI-22-0581. doi: 10.1158/1055-9965.EPI-22-0581. [Epub ahead of print]. PubMed

Beaber EF, Kamineni A, Burnett-Hartman AN, Hixon B, Kobrin SC, Li CI, Oliver M, Rendle KA, Skinner CS, Todd K, Zheng Y, Ziebell RA, Breslau ES, Chubak J, Corley DA, Greenlee RT, Haas JS, Halm EA, Honda S, Neslund-Dudas C, Ritzwoller DP, Schottinger JE, Tiro JA, Vachani A, Doria-Rose VP. Evaluating and improving cancer screening process quality in a multilevel context: the PROSPR II consortium design and research agenda. Cancer Epidemiol Biomarkers Prev. 2022 Aug 2;31(8):1521-1531. doi: 10.1158/1055-9965.EPI-22-0100. PubMed

 

Research

Animal-care-giver_service-dog_with-patient_1col.jpg

How did the pandemic impact hospital visits with animals?

Top pediatric oncology hospitals reported lasting changes to programs involving visits with animals.

Healthy findings blog

QA_Cancer-Harm_illustration_1col.jpg

Improving reporting of cancer screening harms

Aruna Kamineni, PhD, MPH, discusses her recent study on how guidelines report screening risks.

VOICE STUDY

Man sitting at table typing on computer

Understanding young adults’ experiences with cancer

The VOICE study aims to improve the health and health care of people who had cancer as adolescents and young adults.